These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1557359)

  • 1. Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients.
    Van Nostrand WE; Wagner SL; Shankle WR; Farrow JS; Dick M; Rozemuller JM; Kuiper MA; Wolters EC; Zimmerman J; Cotman CW
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2551-5. PubMed ID: 1557359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity.
    Hock C; Golombowski S; Müller-Spahn F; Naser W; Beyreuther K; Mönning U; Schenk D; Vigo-Pelfrey C; Bush AM; Moir R; Tanzi RE; Growdon JH; Nitsch RM
    Eur Neurol; 1998; 39(2):111-8. PubMed ID: 9520072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid.
    Portelius E; Brinkmalm G; Tran A; Andreasson U; Zetterberg H; Westman-Brinkmalm A; Blennow K; Ohrfelt A
    Exp Neurol; 2010 Jun; 223(2):351-8. PubMed ID: 19559702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic correlations of soluble amyloid beta-protein precursor in cerebrospinal fluid in patients with Alzheimer disease and controls.
    Peskind ER; Leverenz J; Farlow MR; Ito RK; Provow SA; Siegel RS; Cleveland M; Morgan CH; Pandian MR; Corbin S; Nochlin D; Schellenberg GD; Raskind MA; Wagner SL
    Alzheimer Dis Assoc Disord; 1997 Dec; 11(4):201-6. PubMed ID: 9437437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease.
    García-Ayllón MS; Lopez-Font I; Boix CP; Fortea J; Sánchez-Valle R; Lleó A; Molinuevo JL; Zetterberg H; Blennow K; Sáez-Valero J
    Sci Rep; 2017 May; 7(1):2477. PubMed ID: 28559572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid.
    Ma QL; Galasko DR; Ringman JM; Vinters HV; Edland SD; Pomakian J; Ubeda OJ; Rosario ER; Teter B; Frautschy SA; Cole GM
    Arch Neurol; 2009 Apr; 66(4):448-57. PubMed ID: 19364929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frameshifted beta-amyloid precursor protein (APP+1) is a secretory protein, and the level of APP+1 in cerebrospinal fluid is linked to Alzheimer pathology.
    Hol EM; van Dijk R; Gerez L; Sluijs JA; Hobo B; Tonk MT; de Haan A; Kamphorst W; Fischer DF; Benne R; van Leeuwen FW
    J Biol Chem; 2003 Oct; 278(41):39637-43. PubMed ID: 12900421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis-Dutch type share a decrease in cerebrospinal fluid levels of amyloid beta-protein precursor.
    Van Nostrand WE; Wagner SL; Haan J; Bakker E; Roos RA
    Ann Neurol; 1992 Aug; 32(2):215-8. PubMed ID: 1510361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative changes in the amyloid beta A4 precursor protein in Alzheimer cerebrospinal fluid.
    Prior R; Mönning U; Schreiter-Gasser U; Weidemann A; Blennow K; Gottfries CG; Masters CL; Beyreuther K
    Neurosci Lett; 1991 Mar; 124(1):69-73. PubMed ID: 1677459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis and quantitation of the beta-amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients with a monoclonal antibody-based immunoassay.
    Henriksson T; Barbour RM; Braa S; Ward P; Fritz LC; Johnson-Wood K; Chung HD; Burke W; Reinikainen KJ; Riekkinen P
    J Neurochem; 1991 Mar; 56(3):1037-42. PubMed ID: 1899691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The beta amyloid protein precursor: mRNAs, membrane-associated forms, and soluble derivatives.
    Palmert MR; Podlisny MB; Golde TE; Cohen ML; Kovacs DM; Tanzi RE; Gusella JF; Whitehouse PJ; Witker DS; Oltersdorf T
    Prog Clin Biol Res; 1989; 317():971-84. PubMed ID: 2513588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid beta protein levels in cerebrospinal fluid are elevated in early-onset Alzheimer's disease.
    Nakamura T; Shoji M; Harigaya Y; Watanabe M; Hosoda K; Cheung TT; Shaffer LM; Golde TE; Younkin LH; Younkin SG
    Ann Neurol; 1994 Dec; 36(6):903-11. PubMed ID: 7998778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid beta-peptide in cerebrospinal fluid in individuals with the Swedish Alzheimer amyloid precursor protein mutation.
    Lannfelt L; Basun H; Vigo-Pelfrey C; Wahlund LO; Winblad B; Lieberburg I; Schenk D
    Neurosci Lett; 1995 Oct; 199(3):203-6. PubMed ID: 8577398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations between soluble α/β forms of amyloid precursor protein and Aβ38, 40, and 42 in human cerebrospinal fluid.
    Gabelle A; Roche S; Gény C; Bennys K; Labauge P; Tholance Y; Quadrio I; Tiers L; Gor B; Chaulet C; Vighetto A; Croisile B; Krolak-Salmon P; Touchon J; Perret-Liaudet A; Lehmann S
    Brain Res; 2010 Oct; 1357():175-83. PubMed ID: 20713025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Site amyloid precursor protein-cleaving enzyme 1 activity is related to cerebrospinal fluid concentrations of sortilin-related receptor with A-type repeats, soluble amyloid precursor protein, and tau.
    Tsolakidou A; Alexopoulos P; Guo LH; Grimmer T; Westerteicher C; Kratzer M; Jiang M; Bujo H; Roselli F; Leante MR; Livrea P; Kurz A; Perneczky R
    Alzheimers Dement; 2013 Jul; 9(4):386-91. PubMed ID: 23127467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease.
    Brinkmalm G; Brinkmalm A; Bourgeois P; Persson R; Hansson O; Portelius E; Mercken M; Andreasson U; Parent S; Lipari F; Ohrfelt A; Bjerke M; Minthon L; Zetterberg H; Blennow K; Nutu M
    Brain Res; 2013 Jun; 1513():117-26. PubMed ID: 23541617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel APP/Abeta isoforms in human cerebrospinal fluid.
    Portelius E; Brinkmalm G; Tran AJ; Zetterberg H; Westman-Brinkmalm A; Blennow K
    Neurodegener Dis; 2009; 6(3):87-94. PubMed ID: 19229112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal study of cerebrospinal fluid amyloid proteins and apolipoprotein E in patients with probable Alzheimer's disease.
    Pirttilä T; Koivisto K; Mehta PD; Reinikainen K; Kim KS; Kilkku O; Heinonen E; Soininen H; Riekkinen P; Wisniewski HM
    Neurosci Lett; 1998 Jun; 249(1):21-4. PubMed ID: 9672379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An abnormality of plasma amyloid protein precursor in Alzheimer's disease.
    Bush AI; Whyte S; Thomas LD; Williamson TG; Van Tiggelen CJ; Currie J; Small DH; Moir RD; Li QX; Rumble B
    Ann Neurol; 1992 Jul; 32(1):57-65. PubMed ID: 1642473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defined neurofilament, tau, and beta-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques.
    Arai H; Lee VM; Otvos L; Greenberg BD; Lowery DE; Sharma SK; Schmidt ML; Trojanowski JQ
    Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2249-53. PubMed ID: 1690426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.